Nicoya Lifesciences is an early stage nanotechnology company developing diagnostic products that will change the world of healthcare. With its revolutionary diagnostic technology, Nicoya empowers people to monitor and care for themselves with unprecedented mobility, confidence, and ease.
Nicoya and Dr. Vladimir Kitaev from Wilfrid Laurier University have been awarded funding through the NSERC Engage program to develop new nanomaterials for advanced sensor technologies
Nicoya has been selected as a Top 10 Innovator at the 2013 Connected Health Symposium!
Nicoya receives Phase 1 funding from the OCE Market Readiness program to further develop their innovative diagnostic technology!
Nicoya and Dr. Juewen Liu from the Unviersity of Waterloo have been awarded funding through the NSERC Engage program to develop advanced aptamer sensor technologies
570 News interviewed CEO Ryan Denomme about using smartphones to screen for cancer and monitor your health and wellness. Listen to the clip on our News page!
CEO Ryan Denomme gives an invited talk on “Diagnostics for congestive heart failure” at the Health Technology Forum Meetup on Cardiovascular Disease in Toronto.
Nicoya finishes 2nd out of 50 companies at the SPIE Photonics West Startup Challenge in San Francisco! They also took home the People's Choice Award for Best Pitch!